Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

European Union
Commission of the European Communities v République de Finlande (C-229/00)
Judgment
Substance
The complaint concerning the decisions…
Findings of the Court
38

Commission of the European Communities v République de Finlande (C-229/00)

Judgment of 12 Jun 2003law://eu/cjeu/2000/c-229-00/para_38@2026-11-10

38The decisions pursuant to which certain medicinal products qualify for higher-rate cover constitute a means of determining the extent of the range of medicinal products covered by the sickness insurance scheme and likely to be used in the treatment of such or such an illness.

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Key facts

Court: Court of Justice
Case: C-229/00 · ECLI:EU:C:2003:334
Decided: 12 Jun 2003
Procedure: Infringement action
Applicant: Commission of the European Communities, represented by I. Koskinen and H. Støvlbæk, acting as Agents, with an address for service in Luxembourg
Defendant: Republic of Finland, represented by T. Pynnä and E. Bygglin, acting as Agents, with an address for service in Luxembourg
Rapporteur: F. Macken
Advocate General: A. Tizzano
Bench: 4 judges
C. Gulmann, V. Skouris, F. Macken, J.N. Cunha Rodrigues
Official: CURIA · EUR-Lex 62000CJ0229

Topics

Approximation of laws

History · 1 version

12 Jun 2003Reading

Connections

Cited by 11: The Queen, on the application of Association of the British Pharmaceutical Industry v Medicines and Healthcare Products Regulatory Agency (C-62/09)2 provisions; LFB Biomédicaments SA and Others v Ministre des Finances et des Comptes publics and Ministre des Affaires sociales et de la Santé (C-271/14, C-273/14)3 provisions; Les Laboratoires Servier SA v Ministre des Affaires sociales et de la Santé and Ministre de l'Économie et des Finances (C-691/13)2 provisions; European Commission v Kingdom of the Netherlands (C-576/10)2 provisions; A. Menarini Industrie Farmaceutiche Riunite Srl and Others v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA), Sanofi Aventis SpA v Agenzia Italiana del Farmaco (AIFA), IFB Stroder Srl v Agenzia Italiana del Farmaco (AIFA), Schering Plough SpA v Agenzia Italiana del Farmaco (AIFA), Bayer SpA v Agenzia Italiana del Farmaco (AIFA) and Ministero della Salute, Simesa SpA v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA), Abbott SpA v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA), Baxter SpA v Agenzia Italiana del Farmaco (AIFA) and SALF SpA v Agenzia Italiana del Farmaco (AIFA) and Ministero della Salute (C-352/07); Commission of the European Communities v Republic of Austria (C-311/07); Commission of the European Communities v Republic of Finland (C-195/04); G. Pohl-Boskamp GmbH & Co. KG v Gemeinsamer Bundesausschuss (C-317/05)2 provisions; Glaxosmithkline SA v Belgian State (C-296/03)2 provisions; Merck, Sharp & Dohme BV v Belgian State (C-245/03)2 provisions; Commission of the European Communities v French Republic (C-280/02)2 provisions
Cites 6: Treaty on the Functioning of the European Union (consolidated 2016)2 provisions; Commission of the European Communities v French Republic (C-159/94); Commission of the European Communities v Republic of Austria (C-424/99); Commission of the European Communities v Italian Republic (C-365/97); Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems; Commission of the European Communities v Italian Republic (C-263/99)